Skip to main content

Table 3 Comparative analysis of PK between indacaterol maleate and acetate on Day 14

From: Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patients

 

Indacaterol maleate 150 μg o.d.

(N = 51)

Indacaterol acetate 150 μg o.d.

(N = 52)

Indacaterol acetate versus Indacaterol maleate

Geometric LSM ratio (90% CI)

 AUC0-24h,ss, h*pg/mL

2180 (2020 to 2350)

1950 (1820 to 2100)

0.897 (0.854 to 0.942)

 Cmax,ss, pg/mL

253 (236 to 273)

226 (210 to 243)

0.891 (0.846 to 0.939)

  1. AUC Area under the curve, Cmax Maximum plasma concentration, LSM Least square mean, o.d. Once daily, PK Pharmacokinetics